QT
IBRX icon

Quantamental Technologies’s ImmunityBio IBRX Stock Holding History

Quantamental Technologies’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$17.2K Sell
10,156
-300
-3% -$602 0.02% 284
2023
Q2 		$29.1K Sell
10,456
-1,300
-11% -$3.68K 0.01% 450
2023
Q1 		$21.4K Sell
11,756
-1,999
-15% -$6.21K 0.01% 403
2022
Q4 		$69.7K Buy
+13,755
New +$75.5K 0.03% 419

Other funds holding IBRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AH
Allen Holding New York $1.01B AUM 27.61% 1-Year Est. Return

Quantamental Technologies's IBRX Position: Q3 2023 in Review

Quantamental Technologies reduced its ImmunityBio (IBRX) stake by 2.9% in Q3 2023, selling an estimated $602 and leaving 10,156 shares worth $17.2K. The position accounts for 0.02% of the portfolio, ranked #284.

Quantamental Technologies first reported a position in IBRX in Q4 2022 and has held it in 4 quarters since. The position peaked at $69.7K in Q4 2022. 131 funds tracked by Wall St. Rank hold IBRX as of Q3 2023.

  • Quantamental Technologies held 10,156 shares of ImmunityBio worth $17.2K as of Q3 2023.
  • Quantamental Technologies sold 300 ImmunityBio shares in Q3 2023, an estimated $602.
  • ImmunityBio made up 0.02% of Quantamental Technologies's portfolio in Q3 2023, its #284 holding.
  • Quantamental Technologies first reported a position in ImmunityBio in Q4 2022 and has held it in 4 quarters since.
  • Quantamental Technologies's ImmunityBio position peaked at $69.7K in Q4 2022.
  • 131 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.